Lunit SCOPE PD-L1 22C3 TPS
Lunit SCOPE is an Artificial Intelligence (AI)-based digital pathology image analysis software that empower pathologists to improve accuracy, scoring agreement, and workflow efficiency. Lunit SCOPE PD-L1 assists in the detection and quantification of PD-L1 expression in NSCLC tissue stained with PD-L1 22C3 pharmDx assay.
Lunit SCOPE is For Research Use Only and not intended for clinical diagnostic use. Lunit SCOPE accessed via the Aperio HALO AP image management system.
Zoom image Instant and automated identification of PD-L1 positive and negative tumor cells
Trained with 1M+ cell annotations by 150+ pathologists worldwide, Lunit SCOPE PD-L1 quickly calculates PD-L1 tumor cell positivity and enable visualization at a cellular level.
Accurate tumor proportion score (TPS) on whole slide image (WSI) level or in Area of Interest (AoI)
Reliable assessment of TPS (tumor proportion score) that helps reducing intra- and inter-observer discrepancy and improve accuracy for edge cases.
Visualization of PD-L1 expression on the cutoff map
Lunit SCOPE PD-L1 TPS cutoff map offers visual identification of PD-L1 expression into 3 cut-off classifications (≥50%, 1-49%, <1%) for deeper understanding on intra-tumoral heterogeneity.
Specifications
| Scanner: | Compatible file types include Leica (.svs), Philips (.iSyntax, .tiff), 3D Histech (.mrxs), Hamamatsu (.ndpi) and other scanners at x40 maginication |
| IMS: | Leica |
| Algorithm: | Lunit SCOPE PD-L1 |
| Assay: | PD-L1 IHC 22C3 pharmDx |
| Tissue Type: | NSCLC |
| Scoring: | TPS |
| Regulatory status: | Research Use Only (RUO) |